Pharma CRM Goes on the iPad and iPhone

Media-SoftMedia-Soft, CRM solutions provider for pharmaceutical companies, announced the launch of the native and offline iPhone adn iPad Pharma CRM application with advanced and unique features that increase the Sales Force effectiveness in pharma organizations.

"Fast, simple, functional and revolutionary are the main goals of our Sales Force Effectiveness solutions for the iPhone, iPad and iPod Touch platforms. Now every sales rep can handle customers offline on the iPad, iPhone or iPod Touch via Sales Vision iTouch application, it's so simple," commented Mr. Damir Safaric, Media-Soft CEO. "It is called Sales Vision iTouch, the best way for Pharma CRM that can revolutionize the pharma processes and increase the sales rep efficiency."

The Pharma CRM application has a simple and comfortable natural user interface that has retained all the functionality of the original Sales Vision® and in special the access to the database online and offline, all actions can be moved to the PC version through the user friendly and intuitive touch screen navigation. Also Sales Vision iTouch enables a parallel use of platforms, so a sales rep can use the iPhone or iPad on the sales field and when he arrives home he can add new information's via his PC version, Sales Vision 9 WIN.

"There are many reasons why Sales Vision CRM goes to the iPhone. Sales Vision® and iPhone are similar because they both have remained true to its roots. Both operate in niches and seek to satisfy their customers. Sales Vision® looks better than ever on iPhone. Also if you look ten years ago, the main add value and motivation factor for a sales rep was to gain a laptop. Times have changed and today the add value is to have the best Smartphone," concluded Mr. Safaric.

For further information, please visit:
http://www.media-soft.info

About Media-Soft
The story of Media Soft begins in 1996 when a visionary man started up a company that must be the best in the pharmaceutical field. Today that mission is done, Media-Soft operates in more then 30 countries worldwide, on 3 continents and has over 6.000 licensed users of its software Sales Vision®. Media Soft is established on many locations. The HQ is in Cakovec and London. We also have partners and support teams worldwide in following countries: Mexico City, Bratislava, Warszawa and Moscow. Some of the customer are Pfizer, Krka, Sandoz, Solvay, Abbott, Alkaloid, GSK, Nycomed, Roche, Bayer Schering Pharma and many others.

Most Popular Now

Aspirin green light for brain bleed stroke patient…

People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major ...

Cancer cells are quick-change artists adapting to …

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed...

APRINOIA Therapeutics awarded grant from The Micha…

APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that...

Benralizumab not effective reducing exacerbations …

More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, according t...

Pfizer announces top-line results from Phase 3 Tri…

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age wi...

Novartis phase II data for new inhaled combination…

Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol ac...

New data show Symbicort reduces attacks in mild as…

New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol)...

Cannabis use among older adults rising rapidly

Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their docto...

Merck pioneers new effort to see MS from the insid…

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple ...

Amgen joins with community oncology networks for n…

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiat...

Bayer receives U.S. FDA breakthrough therapy desig…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patie...

Roche's personalised medicine entrectinib shrank t…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced positive data from the Phase I/II STARTRK-NG study, evaluating the investigational medicine entrectinib in children and adole...